品牌故事

Brand Story of Hanvet


上海汉维生物医药科技有限公司位于著名的上海张江高科技园区,是集宠物药品研发、生产、销售于一体的国际化高新技术企业。

2008年,美国次贷危机引发的金融危机席卷全球。促使众多行业的产业升级、结构性调整迫在眉睫,随着人口红利逐年减少,劳动力成本不断上升,环境污染日益加重,中国更是急需由原本粗犷的化学原料药出口向制剂产业升级转型,上海汉维生物医药科技有限公司适时而生。

凭借着与国际贸易伙伴多年的合作关系与良好的信誉,上海汉维生物医药科技有限公司成立之初就接到了国际知名动物医药企业制剂研发的外包项目,上海汉维以专业、认真、严谨的工作态度以及准时、高质量的研发成果和研究报告给客户留下了深刻印象,由此,上海汉维迈出了动物药制剂研发的第一步。

Located in Zhangjiang high-tech park (shanghai, China), Shanghai Hanvet Bio-Pharm Co.,Ltd(hereafter referred to as “Shanghai Hanvet”) is a high and new technology enterprise with the integration of R&D, manufacture and sales of companion animal healthcare products.

In 2008, the economic crisis caused by the subprime crisis in USA swept the world, which urged the upgrading of industries and structural adjustment of numerous industries. With the reduction of demographic dividend year by year, the increase of labor cost and the worsening environmental pollution, it was extremely urgent for pharmaceutical industry in China to upgrade from the export of raw material to finished products. Shanghai Hanvet was founded in that period.

Relying on long-term cooperative relationship with overseas customers through international business, as well as its well-deserved reputation, Shanghai Hanvet started outsourcing projects of R&D of veterinary formulations, undertaking from well-known multinational veterinary pharmaceutical companies in its early days. Working under professional, earnest and rigorous attitude, Shanghai Hanvet impressed customers by in-time and high qualified R&D achievements and research reports. Thereof Shanghai Hanvet took its first step of veterinary formulations.

其后,畜牧业发达的国际合作伙伴,如澳大利亚、新西兰和巴西等国的动物药品公司,不断向汉维的研发平台提出新的动物药品研发项目,凭借专业化、成本低、效率高的优势,上海汉维成功的完成了几十个产品的处方开发和方法学研究,其中一些项目更是进一步实现了合同生产并出口销售的商业化运营,达到与合作伙伴共赢的局面。汉维也拥有了中国第一家按照欧洲GLP要求规范管理的动物药品研发实验室。

In the years afterwards, Shanghai Hanvet has been undertaking outsourcing projects of R&D of veterinary formulations from international veterinary pharmaceutical companies constantly. Depending on its advantage of specialization, lower cost and higher efficiency, Shanghai Hanvet successfully accomplished formulation development and methodology research for dozens of products. Some projects have been commercially operated by contract manufacturing and export, from which Shanghai Hanvet and its customers achieved a win-win cooperation. After years of development, Shanghai Hanvet has accumulated rich experience of R&D of veterinary formulations, mastered advanced pharmaceutical technology, and founded a professional R&D team leading by world famous technical experts of veterinary medicines. Shanghai Hanvet also founded the first professional R&D and analysis laboratory for veterinary medicines in China, which is designed and operated according to EU GLP standards.

在承接国外公司动物药品研发外包和合同生产的同时,上海汉维注意到中国伴侣动物药品市场的空白。随着中国GDP的持续增长,宠物已成为很多家庭的重要成员,宠物诊疗需求也急剧增加。但由于药物研发和申报注册的高昂投入及周期漫长,同时不规范的市场充斥着大量廉价的虚假文号、没有注册或走私的宠物药品等等,使得生产投资巨大的合规新药难以销售或陷入亏损,因而很少中国企业愿意投入大量资金研发、生产和推广合规新药。在欧美等国家地区,官方对动物药和人用药实施完全相同的药品注册、生产和销售管理规范,并且由同一管理机构FDA或EDQM严格管理,制售假药的行为将受到严重的惩罚,几乎没有企业会去制假售假,因此推动了动物药品市场的健康发展,高水平的动物保健促进了人与动物的和谐相处,提高了家庭生活快乐和质量。短短十多年,国际上宠物药品的销售额已超过整个兽药市场份额的50%,然而中国自己的合法合规产品近乎空白,中国亟需合法、合规、安全、有效的宠物专用药物和规范诊疗服务。

brandimg01

While undertaking outsourcing of R&D of veterinary medicines and contract manufacturing projects, Shanghai Hanvet noticed the market vacancy and the increasing need of companion animal healthcare products in China. With continuous increase of GDP in China, companion animals become the very important family member in many families. The demand of diagnosis and treatment service is sharply increasing. But in Chinese market, because of the huge investment and long cycle of R&D and registration of veterinary medicines, there are a great number of false companion animal healthcare medicines with false product license , or many human products which is not suitable for companion animal use in dosage, even some non-registration products or some products from smuggling importing. As a result, very few Chinese pharmaceutical companies are willing to invest high cost in R&D, manufacturing and marketing new and regulated medicines for companion animal use, which is totally opposite to developed countries like European and the America, where management practices of veterinary medicines and human medicines are implemented the same, and controlled uniformly and strictly by authorities of FDA or EDQM. In these countries and regions, companies manufacturing and selling fake medicines will be given serious punishment, so barely companies manufacture and sell fake medicines, which motivates the healthy development of companion animal healthcare medicines market. The high level of animal health promotes the harmonious relationships between animals and mankind, and also improves the happiness and better quality of their life. In a short period of ten years, the sales of companion animal healthcare medicines in global has occupied more than 50% market share of the whole veterinary medicines market. In the meantime, there is nearly non-existence of high qualified product and brand of Chinese companies. Obviously, regulated, safe and effective companion animal healthcare medicines as well as diagnosis and treatment services are desperately needed in China.

2009年开始上海汉维斥巨资不断增添国际最先进的研发检测设备,聘请国际知名技术专家领衔研发和注册国际上最前沿的动物药品,突破性地研发出安全有效、使用方便、适口性良好、计量精确的宠物专用药品,立志为中国宠物健康贡献一份力量。

秉承着“诚正专致,严谨创新”的精神,经过5年的不懈努力,汉维在2013年获得第一个国家二类新兽药。随后,又相继获得4个国家新兽药证书,成为近年来获得宠物类国家新兽药证书最多的中国企业。同时公司凭借领先、雄厚的研发实力获得多项专利证书,并获得上海市科技型中小企业创新基金等奖项。

201701041730363036

Since 2009, Shanghai Hanvet has been invested huge in introduction of the most advanced R&D and testing equipment in the world, and hired world famous technical experts to lead the R&D and registration of the most cutting-edge companion animal healthcare medicines in the world. In a breakthrough, Shanghai Hanvet has developed safe, effective, convenient to use, palatable and accurately measured companion animal healthcare medicines. It is the hope of Shanghai Hanvet to develop high-end companion animal healthcare medicines of China, and to provide professional marketing services to customers.

Obedience to the corporate value of ”With integrity and expertise, strive for rigor and innovation”, and through five years’ tireless efforts, Shanghai Hanvet were approved 2 new veterinary drugs certificates in China in 2013, and another 4 new veterinary drugs certificates in 2015, becoming a company that acquires the most new veterinary drugs certificates dedicated for pet use in China in recent years. In the meantime, depending on its leading and tremendous strength in R&D, Shanghai Hanvet has been approved a number of China National invention patents, and has been granted small and mid-sized enterprise innovation fund in science and technology field, and National Hi-tech Enterprise Authenticated Certificate.

201701041733413341

在制剂研发、新药注册获得国内外专家及政府认可的同时,上海汉维创建了中国首个高端宠物医药品牌“汉维宠仕(R)”,立志于把汉维宠仕(R)打造成为中国最优秀的国际化专业宠物健康领先品牌。在生产上,上海汉维与国内最优秀的动物药品公司合作严格按照国家药品GMP良好生产管理规范组织生产。在销售服务上,建立了自己的高素质、经验丰富的全国性专业化团队和客户服务呼叫中心,严格遵循国家药品GSP良好销售管理规范实施销售,及时为客户提供合法、合规、安全、有效的宠物专用药品和专业服务。同时,上海汉维建立了先进的订单和物流管理系统以帮助用户及时和方便的得到所需的产品。2015年,汉维宠仕(R)的两个吉祥物Hansen和Vicky加入了上海汉维,它们将引导宠物医生和宠物主人走进我们的每一个产品,介绍每一个产品的适应症和使用方法,它们将帮助宠物小伙伴们早日回到健康快乐的幸福生活中。

随着中国经济的蓬勃发展,越来越多的家庭拥有了可爱的伴侣动物,宠物成为很多家庭不可或缺的成员。汉维宠仕(R)将为中国的宠物宝宝们带来更多国际领先水平的宠物专用医药保健产品,让中国越来越多的宠物得到良好的健康保障。“一切为了更放心”,上海汉维将倾听用户的心声,了解用户的需求,重视用户感受,通过每一天的努力使汉维宠仕(R)成为值得信赖的中国最优秀的国际化专业宠物健康领先品牌。

brandimg04


While its R&D of preparations and registration of new veterinary drugs being approved by foreign and domestic experts as well as authorities, Shanghai Hanvet has founded the first high-end brand of companion animal healthcare medicines in China, ”Hanvet Pet Health”, and is aspiring to making it the best international and professional companion animal healthcare brand. Shanghai Hanvet organizes production strictly complying with GMP(Good Manufacturing Practice). Shanghai Hanvet has established a national sales team with high-qualified and experienced sales personnel, as well as a comprehensive customer service call center. Strictly complying with GSP(Good Supply Practice). Shanghai Hanvet provides customers with regulated, safe, effective pet medicines and professional services. Meanwhile, Shanghai Hanvet has established an advanced order and logistics management system, which enables customers to acquire products in-time and conveniently. In 2015, Hansen and Vicky, two mascots of Hanvet pet health, join Shanghai Hanvet. They will introduce veterinarian and pet owners with indication and application method of each product to help pets recover and live a happy life.

With the flourish of China’s economy, more and more families own their adorable companion animals, and pets are becoming indispensible family members. Hanvet pet health will bring pets in China with more and more advanced pet health care products and health security. Motivated by its slogan of “All for your trust”, Shanghai Hanvet listens to customers’ demand and treasure consumers' response. Through endeavor every day, Hanvet Pet Health becomes the most leading international and professional pet health brand in China.

brandimg05